scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Immunization Programs economics"

1 - 10 of 2,147 results for
 "Immunization Programs economics"
Results per page:

Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine (Hexaxim®) in the Colombian Expanded Program on Immunization.

Publication Type: Academic Journal

Source(s): Value in health regional issues [Value Health Reg Issues] 2021 Dec; Vol. 26, pp. 150-159. Date of Electronic Publication: 2021 Aug 30.

Abstract: Objectives: To evaluate cost implications of a hexavalent vaccine (diphtheria, tetanus, and acellular pertussis [DTaP]-inactivated polio vaccine [IPV]-hepatitis B [HB]-Haemophilus influenzae type B [Hib] polysaccharide conjugated to T protein [PRP∼T]) ...

View details

The fight to manufacture COVID vaccines in lower-income countries.

Publication Type: Periodical

Source(s): Nature [Nature] 2021 Sep; Vol. 597 (7877), pp. 455-457.

Authors:
View details

A visual approach to the economic evaluation of vaccines: opening the health economic black box.

Publication Type: Academic Journal

Source(s): Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Oct; Vol. 21 (5), pp. 985-994. Date of Electronic Publication: 2021 Mar 18.

Abstract: Objectives: The economic evaluation of vaccines has attracted a great deal of controversy. In the academic literature, several vaccination advocates argue that the evaluation frame for vaccines should be expanded to give a more complete picture of thei...

View details

Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.

Publication Type: Academic Journal

Source(s): The Pediatric infectious disease journal [Pediatr Infect Dis J] 2020 May; Vol. 39 (5), pp. 460-465.

Authors:

Abstract: Background: Since the introduction of 2 rotavirus (RV) vaccines in Korea, the vaccination rate has reached over 80% with out-of-pocket spending in the private market. We investigated the socioeconomic impact of RV vaccines in Korea to assess their valu...

View details

World Bank grants for global vaccination - why so slow?

Publication Type: Academic Journal

Source(s): Nature [Nature] 2021 Jun; Vol. 594 (7864), pp. 475.

Authors:
View details

Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries.

Publication Type: Academic Journal

Source(s): International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Jun 13; Vol. 19 (12). Date of Electronic Publication: 2022 Jun 13.

Abstract: The need for an anti-COVID-19 booster dose posed an organizational challenge for health policy makers worldwide. Therefore, this study aimed to explore the health policies regarding the booster dose through an overview of recommendations issued in high...

View details

Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.

Publication Type: Academic Journal

Source(s): PloS one [PLoS One] 2021 May 13; Vol. 16 (5), pp. e0251644. Date of Electronic Publication: 2021 May 13 (Print Publication: 2021).

Abstract: Objectives: Comprehensive cost-effectiveness analyses of introducing varicella and/or herpes zoster vaccination in the Swedish national vaccination programme.Design: Cost-effectiveness analyses based on epidemiological results from a specifically devel...

View details

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

Publication Type: Academic Journal

Source(s): Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 May; Vol. 24 (5), pp. 625-631. Date of Electronic Publication: 2021 Feb 19.

Abstract: The potential health and economic value of a vaccine for coronavirus disease (COVID-19) is self-evident given nearly 2 million deaths, "collateral" loss of life as other conditions go untreated, and massive economic damage. Results from the first licen...

View details

What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model.

Publication Type: Academic Journal

Source(s): Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 50-60. Date of Electronic Publication: 2020 Nov 14.

Abstract: Objectives: The value of chickenpox vaccination is still debated in the literature and by jurisdictions worldwide. This uncertainty is reflected in the inconsistent uptake of the vaccine, where some countries offer routine childhood immunization progra...

View details

Survival of the Wealthiest?

Publication Type: Editorial & Opinion

Source(s): The EMBO journal [EMBO J] 2020 Dec 01; Vol. 39 (23), pp. e107227. Date of Electronic Publication: 2020 Nov 18.

Abstract: A number of promising COVID-19 vaccine candidates may pass approval this month. However, the pandemic will only be brought into check through an equitable, epidemiologically informed distribution policy. The health emergency provides a unique opportuni...

View details
sponsored